Carcinogenesis Advance Access originally published online on October 24, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 25, No. 2, 289-297,
February 2004
© Oxford University Press; all rights reserved
CARCINOGENESIS |
Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo
1 Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198-6805 and 2 Department of Chemistry, Washington University, One Brookings Drive, St Louis, MO 63130, USA
Studies of estrogen metabolism, formation of DNA adducts, carcinogenicity, cell transformation and mutagenicity have led to the hypothesis that reaction of certain estrogen metabolites, predominantly catechol estrogen-3,4-quinones, with DNA can generate the critical mutations initiating breast, prostate and other cancers. The endogenous estrogens estrone (E1) and estradiol (E2) are oxidized to catechol estrogens (CE), 2- and 4-hydroxylated estrogens, which can be further oxidized to CE quinones. To determine possible DNA adducts of E1(E2)-3,4-quinones [E1(E2)-3,4-Q], we reported previously that the reaction of E1(E2)-3,4-Q with dG produces the depurinating adduct 4-hydroxyE1(E2)-1-N7Gua [4-OHE1(E2)-1-N7Gua] by 1,4-Michael addition (Stack et al., Chem. Res. Toxicol., 1996, 9, 851). We report here that reaction of E1(E2)-3,4-Q with Ade results in the formation of 4-OHE1(E2)-1-N3Ade by 1,4-Michael addition. The N7Gua and N3Ade depurinating adducts formed both in vitro and in rat mammary gland in vivo were analyzed by HPLC with electrochemical detection and, for some samples, by LC/MS/MS. When E2-3,4-Q was reacted with DNA in vitro, the depurinating adducts 4-OHE1(E2)-1-N3Ade and 4-OHE1(E2)-1-N7Gua, which are rapidly lost from DNA by cleavage of the glycosyl bond, were formed (>99% of the total adducts), as well as traces of stable adducts, which remain in DNA unless removed by repair. Similar results were obtained when 4-OHE2 was oxidized by horseradish peroxidase, lactoperoxidase, tyrosinase or phenobarbital-induced rat liver microsomes in the presence of DNA. When 4-OHE2 or E2-3,4-Q was injected into the mammary glands of female ACI rats in vivo and the mammary tissue was excised 1 h later, the depurinating adducts 4-OHE2-1-N3Ade and 4-OHE2-1-N7Gua constituted >99% of the total adducts formed. In addition, 4-OHE2 conjugates formed by reaction of E2-3,4-Q with glutathione were also detected. These results demonstrate that the 4-CE are metabolized to CE-3,4-Q, which react with DNA to form primarily depurinating adducts. These adducts can generate the critical mutations that initiate cancer (Chakravarti et al., Oncogene, 2001, 20, 7945; Chakravarti et al., Proc. Am. Assoc. Cancer Res., 2003, 44, 180).
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. A. Khan, M. Uddin, Mohd. W. A. Khan, and H. S. Chabbra Catecholoestrogens: possible role in systemic lupus erythematosus Rheumatology, November 1, 2009; 48(11): 1345 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-D. Yu, G.-H. Di, W.-T. Yuan, L. Fan, J. Wu, Z. Hu, Z.-Z. Shen, Y. Zheng, W. Huang, and Z.-M. Shao Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53 Hum. Mol. Genet., July 1, 2009; 18(13): 2502 - 2517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-A. Park, H.-K. Na, E.-H. Kim, Y.-N. Cha, and Y.-J. Surh 4-Hydroxyestradiol Induces Anchorage-Independent Growth of Human Mammary Epithelial Cells via Activation of I{kappa}B Kinase: Potential Role of Reactive Oxygen Species Cancer Res., March 15, 2009; 69(6): 2416 - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Hah, J. M. Mundt, H. M. Kim, R. A. Sumbad, K. W. Turteltaub, and P. T. Henderson From the Cover: Measurement of 7,8-dihydro-8-oxo-2'-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry PNAS, July 3, 2007; 104(27): 11203 - 11208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Belous, D. L. Hachey, S. Dawling, N. Roodi, and F. F. Parl Cytochrome P450 1B1-Mediated Estrogen Metabolism Results in Estrogen-Deoxyribonucleoside Adduct Formation Cancer Res., January 15, 2007; 67(2): 812 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Crooke, M. D. Ritchie, D. L. Hachey, S. Dawling, N. Roodi, and F. F. Parl Estrogens, enzyme variants, and breast cancer: a risk model. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1620 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mesia-Vela, R. I. Sanchez, K. R. Reuhl, A. H. Conney, and F. C. Kauffman Phenobarbital Treatment Inhibits the Formation of Estradiol-Dependent Mammary Tumors in the August-Copenhagen Irish Rat J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 590 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Sissung, D. K. Price, A. Sparreboom, and W. D. Figg Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention Mol. Cancer Res., March 1, 2006; 4(3): 135 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Yager and N. E. Davidson Estrogen Carcinogenesis in Breast Cancer N. Engl. J. Med., January 19, 2006; 354(3): 270 - 282. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Desaulniers, G.-H. Xiao, K. Leingartner, I. Chu, B. Musicki, and B. K. Tsang Comparisons of Brain, Uterus, and Liver mRNA Expression for Cytochrome P450s, DNA Methyltransferase-1, and Catechol-O-Methyltransferase in Prepubertal Female Sprague-Dawley Rats Exposed to a Mixture of Aryl Hydrocarbon Receptor Agonists Toxicol. Sci., July 1, 2005; 86(1): 175 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Desaulniers, G. M. Cooke, K. Leingartner, K. Soumano, J. Cole, J. Yang, M. Wade, and A. Yagminas Effects of Postnatal Exposure to a Mixture of Polychlorinated Biphenyls, p,p'-dichlorodiphenyltrichloroethane, and p-p'-dichlorodiphenyldichloroethene in Prepubertal and Adult Female Sprague-Dawley Rats International Journal of Toxicology, March 1, 2005; 24(2): 111 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, F. L. Meyskens Jr., G. S. Omenn, B. Valanis, and J. H. Williams Jr. The Beta-Carotene and Retinol Efficacy Trial: Incidence of Lung Cancer and Cardiovascular Disease Mortality During 6-Year Follow-up After Stopping {beta}-Carotene and Retinol Supplements J Natl Cancer Inst, December 1, 2004; 96(23): 1743 - 1750. [Abstract] [Full Text] [PDF]
|
|